Loading... Please wait... Loading... Please wait...
ESTIMATED
05/01/2024
05/01/2024
(AS OF MARCH 31)
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 0 | $0.73 | $0.73 | $0.73 |
| Q2 2024 | 3 | $0.74 | $0.79 | $0.77 |
| Q3 2024 | 1 | $0.97 | $0.97 | $0.97 |
| Q4 2024 | 0 | $0.57 | $0.57 | $0.57 |
| Q1 2025 | 1 | $0.89 | $0.89 | $0.89 |
| Q2 2025 | 1 | $0.86 | $0.86 | $0.86 |
| Q3 2025 | 1 | $1.08 | $1.08 | $1.08 |
| Q4 2025 | 1 | $0.63 | $0.63 | $0.63 |
GSK plc last posted its earnings results on Wednesday, May 1st, 2024. The company reported $1.09 earnings per share for the quarter, topping analysts' consensus estimates of $0.94 by $0.15. The company had revenue of 7.36 B for the quarter and had revenue of 30.33 B for the year. GSK plc has generated $1 earnings per share over the last year ($1.2 diluted earnings per share) and currently has a price-to-earnings ratio of 27.16. GSK plc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, July 31st, 2024 based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 05/01/2024 | Q1 2024 | $0.94 | $0.26 | -0.68 | $8.89 B | $7.36 B | 03/05/2024 | Q4 2023 | $0.09 | $9.66 B | $8.05 B | 11/01/2023 | Q3 2023 | $1.09 | $0.36 | -0.73 | $9.37 B | $8.15 B | 07/26/2023 | Q2 2023 | $0.85 | $0.40 | -0.45 | $8.78 B | $7.18 B | 04/26/2023 | Q1 2023 | $0.85 | $0.37 | -0.48 | $8.07 B | $6.95 B | 03/10/2023 | Q4 2022 | $0.37 | $8.90 B | $7.38 B | 11/02/2022 | Q3 2022 | $0.90 | $0.39 | -0.51 | $8.31 B | $7.83 B | 07/27/2022 | Q2 2022 | $0.76 | $0.41 | -0.35 | $7.88 B | $6.93 B | 04/27/2022 | Q1 2022 | $0.93 | $0.90 | -0.03 | $11.75 B | $9.78 B | 03/08/2022 | Q4 2021 | $0.38 | $12.87 B | $9.53 B | 09/30/2021 | Q3 2021 | $0.58 | $11.90 B | $9.08 B | 06/30/2021 | Q2 2021 | $0.70 | $10.45 B | $8.09 B | 03/31/2021 | Q1 2021 | $0.54 | $10.85 B | $7.42 B | 03/12/2021 | Q4 2020 | $0.34 | $11.88 B | $8.74 B | 09/30/2020 | Q3 2020 | $0.63 | $11.45 B | $8.65 B | 06/30/2020 | Q2 2020 | $1.14 | $9.71 B | $7.62 B | 03/31/2020 | Q1 2020 | $0.79 | $10.86 B | $9.09 B | 03/06/2020 | Q4 2019 | $0.66 | $11.78 B | $8.90 B | 09/30/2019 | Q3 2019 | $0.79 | $11.41 B | $9.39 B | 06/30/2019 | Q2 2019 | $0.49 | $9.55 B | $7.81 B |
|---|
A. GSK plc has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, July 31st, 2024 based off last year's report dates.
A. In the previous quarter, GSK plc (NYSE:GSK) reported $1.09 earnings per share (EPS) to beat the analysts' consensus estimate of $0.94 by $0.15.
A. The conference call for GSK plc's latest earnings report can be listened to online.
A. The conference call transcript for GSK plc's latest earnings report can be read online.
A. GSK plc (NYSE:GSK) has a recorded annual revenue of $30.33 B.
A. GSK plc (NYSE:GSK) has a recorded net income of $30.33 B. GSK plc has generated $1.22 earnings per share over the last four quarters.
A. GSK plc (NYSE:GSK) has a price-to-earnings ratio of 27.16 and price/earnings-to-growth ratio is 0.27.
